Insmed Inc. buy Truist Financial Co.
Start price
01.11.24
/
50%
€61.50
Target price
01.11.25
€96.72
Performance (%)
165.04%
End price
02.11.25
€163.00
Summary
This prediction ended on 02.11.25 with a price of €163.00. With a performance of 165.04% the BUY prediction by Truist_Financial_Co_ was a big success. Truist_Financial_Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -3.977% | -3.977% | 152.239% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $105.00 price target on the stock, up previously from $100.00.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten

